[ET Net News Agency, 30 January 2024] Daiwa upgraded the rating of Wuxi Bio (02269) to
"buy" from "hold" and maintained the target price at HKD33.
The research house said while its 2024E top-line/earnings are 7%/9% lower, it sees the
current price as an opportunistic entry point for the stock. (RC)